Literature DB >> 11419948

Solution structure of human IL-13 and implication for receptor binding.

F J Moy1, E Diblasio, J Wilhelm, R Powers.   

Abstract

Interleukin-13 has been implicated as a key factor in asthma, allergy, atopy and inflammatory response, establishing the protein as a valuable therapeutic target. The high-resolution solution structure of human IL-13 has been determined by multidimensional NMR. The resulting structure is consistent with previous short-chain left-handed four-helix bundles, where a significant similarity in the folding topology between IL-13 and IL-4 was observed. IL-13 shares a significant overlap in biological function with IL-4, a result of the common alpha chain component (IL-4Ralpha) in their respective receptors. Based on the available structural and mutational data, an IL-13/IL-4Ralpha model and a sequential mechanism for forming the signaling heterodimer is proposed for IL-13. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11419948     DOI: 10.1006/jmbi.2001.4764

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  16 in total

Review 1.  Applications of NMR to structure-based drug design in structural genomics.

Authors:  Robert Powers
Journal:  J Struct Funct Genomics       Date:  2002

2.  Role of IL-13 Genetic Variants in Signalling of Asthma.

Authors:  Madhavi Latha Alasandagutti; Mohd Soheb Sadat Ansari; S R Sagurthi; Vijayalakshmi Valluri; Sumanlatha Gaddam
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

3.  IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation.

Authors:  Frank D Vladich; Susan M Brazille; Debra Stern; Michael L Peck; Raffaella Ghittoni; Donata Vercelli
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 4.  Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease.

Authors:  Steven J Van Dyken; Richard M Locksley
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

5.  STAT6⁻/⁻ mice exhibit decreased cells with alternatively activated macrophage phenotypes and enhanced disease severity in murine neurocysticercosis.

Authors:  Bibhuti B Mishra; Uma Mahesh Gundra; Judy M Teale
Journal:  J Neuroimmunol       Date:  2010-11-03       Impact factor: 3.478

Review 6.  Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins.

Authors:  Christian Fercher; Sahar Keshvari; Michael A McGuckin; Ross T Barnard
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-19

7.  Comprehensive clarification of two paralogous interleukin 4/13 loci in teleost fish.

Authors:  Maki Ohtani; Nobuhiro Hayashi; Keiichiro Hashimoto; Teruyuki Nakanishi; Johannes Martinus Dijkstra
Journal:  Immunogenetics       Date:  2008-06-17       Impact factor: 2.846

8.  Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13Ralpha2.

Authors:  A B Madhankumar; Akiva Mintz; Waldemar Debinski
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

9.  Identification of interleukin genes in Pogona vitticeps using a de novo transcriptome assembly from RNA-seq data.

Authors:  Alexandra Livernois; Kristine Hardy; Renae Domaschenz; Alexie Papanicolaou; Arthur Georges; Stephen D Sarre; Sudha Rao; Tariq Ezaz; Janine E Deakin
Journal:  Immunogenetics       Date:  2016-06-02       Impact factor: 2.846

10.  Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system.

Authors:  Sherry L LaPorte; Z Sean Juo; Jana Vaclavikova; Leremy A Colf; Xiulan Qi; Nicola M Heller; Achsah D Keegan; K Christopher Garcia
Journal:  Cell       Date:  2008-01-25       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.